Part,  Chapter, Paragraph

 1    I,     2.  4    |       men, the excess mortality ranged between 50 and 78 per cent
 2   II,     5.  4.  1|         healthcare expenditures ranged from 1.6% in the Netherlands
 3   II,     5.  5.  3|        in 2000, found ASD rates ranged from one in 222 children
 4   II,     5.  5.  3|         Figure 5.5.3.5.1. RR-MS ranged from 24% (The Netherlands)
 5   II,     5.  5.  3|   proportion of RP-MS and SP-MS ranged from 4% (Sweden) to 50% (
 6   II,     5.  5.  3|        Bulgaria), whereas PP-MS ranged from 4% (Austria) to 35% (
 7   II,     5.  7.  3| incidence rates of RRT for ESRD ranged from 57 patients pmp in
 8   II,     5.  8.  3|      Italy, AO prevalence rates ranged from 11.0% with the ERS
 9   II,     5.  8.  3|         chronic cough or phlegm ranged from 20-30% in mild to about
10   II,     5.  8.  4|          Abnormal lung function ranged from 4% for male never smokers (
11   II,     5.  9.  4|       to occupational exposures ranged from 10% to 25%, equivalent
12   II,     6.  3.  2|      Lithuania and Latvia), but ranged from 0–6% in the rest of
13   II,     6.  3.  7|    overall incidence rates have ranged from 1.45 to 2.27 per 100
14   II,     9.  1.  1|        neonatal mortality rates ranged from 6.4 to 22.1 per 1 000
15   II,     9.  1.  1|    Member States. By 2004, they ranged from 1.6 to 9.5 per 1 000
16   II,     9.  2.  3|         which could supply data ranged from 3.0% in Romania and
17   II,     9.  3.  3| different or unknown HIV-status ranged from 1/3 in East Germany
18   II,     9.  5.  3|        than men. The difference ranged from 20 minutes in Sweden
19  III,    10.  2.  1|       The prevalence of obesity ranged from 7.4% to 26.6% among
20  III,    10.  4.  3|     European countries coverage ranged between 40% and 60%, while
21  III,    10.  6.  2|       men, the excess mortality ranged between 50 and 78 per cent